Finance

Beta
Lists
9887:HKG
Nanjing Leads Biolabs Co Ltd
HK$56.50
-0.62%
(-0.35) 1D
Jun 5, 4:09:10 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 9887...
Open
HK$57.15
High
HK$57.90
Low
HK$54.30
Mkt. cap
11.59B
Avg. vol.
635.64K
Volume
843.00K
52-wk high
HK$97.50
52-wk low
HK$44.72
EPS
-HK$1.24
No. of employees
244
Open
HK$57.15
High
HK$57.90
Low
HK$54.30
Mkt. cap
11.59B
Avg. vol.
635.64K
Volume
843.00K
52-wk high
HK$97.50
52-wk low
HK$44.72
EPS
-HK$1.24
No. of employees
244
Analyst outlook
Analyst Ratings
Based on 6 analysts giving stock ratings to 9887 in the past 3 months
Strong Buy
Buy
5
Hold
1
Sell
0
12 month forecast
Based on 6 Wall Street analysts offering 12 month price targets for 9887 in the last 3 months.
Highest
Current HK$56.50
HK$140.75 (+149.12%)
Average
HK$104.21 (+84.44%)
Lowest
HK$62.00 (+9.73%)
News stories
From sources across the web
About Nanjing Leads Biolabs Co Ltd
CEO-
Employees244
Founded2012
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
88.63M
88.63M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
57.75M
74.06M
78.64M
78.64M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18.88M
16.95M
23.44M
23.44M
Operating expense
76.63M
91.01M
102.07M
102.07M
Total operating expenses
76.63M
91.01M
102.07M
102.07M
Operating income
-76.63M
-91.01M
-13.45M
-13.45M
Other non operating income
162.00K
-1.18M
-11.63M
-11.63M
EBT including unusual items
-75.37M
-91.03M
-14.75M
-14.75M
EBT excluding unusual items
-75.74M
-91.13M
-14.79M
-14.79M
Income tax expense
-
-
7.76M
7.76M
Effective tax rate
-
-
-52.63%
-52.63%
Other operating expenses
-
-
-
-
Net income
-75.37M
-91.03M
-22.51M
-22.51M
Net profit margin
-
-
-25.40%
-25.40%
Earnings per share
-
-
-
-
Interest and investment income
3.06M
2.36M
12.07M
12.07M
Interest expense
-1.90M
-1.73M
-1.78M
-1.78M
Net interest expenses
1.16M
637.00K
10.29M
10.29M
Depreciation and amortization charges
-
-
-
-
EBITDA
-72.34M
-86.72M
-8.39M
-9.54M
Gain or loss from assets sale
3.00K
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more